Early research (Phase 1)Study completedNCT03309202What this trial is testingStudy of PF-05221304 in Subjects With Varying Degrees of Hepatic ImpairmentWho this might be right forHepatic Impairment Pfizer 24
Early research (Phase 1)Study completedNCT03562117What this trial is testingPharmacokinetics (PK) Study of Gepotidacin (GSK2140944) in Adult Subjects With Varying Degrees of Hepatic Impairment and in Matched Control Subjects With Normal Hepatic FunctionWho this might be right forInfections, Bacterial GlaxoSmithKline 25
Early research (Phase 1)Study completedNCT07248839What this trial is testingAssess the Drug Levels and Safety of BMS-986435 in Participants With Normal Hepatic Function and Participants With Different Degrees of Hepatic ImpairmentWho this might be right forHealthy VolunteersHepatic Impairment Bristol-Myers Squibb 69
Early research (Phase 1)UnknownNCT05747664What this trial is testingTo Compare the Safety and PK/PD Characteristics of Subjects With Between Hepatic Impairment and Normal Hepatic FunctionWho this might be right forDiabetes Mellitus, Type 2 Daewoong Pharmaceutical Co. LTD. 24
Early research (Phase 1)Study completedNCT07018492What this trial is testingPhase 1 Study of BPN14770 in Participants With Hepatic Impairment and Healthy ControlsWho this might be right forHepatic Impairment Shionogi 32
Early research (Phase 1)Study completedNCT03890809What this trial is testingAn Investigational Study of BMS-986165 in Participants With Normal Liver Function and Participants With Mild to Severe Liver DamageWho this might be right forLiver DysfunctionHealthy Volunteers Bristol-Myers Squibb 32
Early research (Phase 1)Study completedNCT01949545What this trial is testingStudy of the Pharmacokinetics and Safety of Carfilzomib in Patients With Advanced Malignancies and Hepatic ImpairmentWho this might be right forSolid TumorsHematologic MalignanciesHepatic Impairment Amgen 46
Large-scale testing (Phase 3)UnknownNCT05595109What this trial is testingRole of Silymarin in Chemotherapy Toxicity and Cognition Improvement in Breast Cancer PatientsWho this might be right forBreast CancerPeripheral NeuropathyCardiac Toxicities+2 more Tanta University 56
Early research (Phase 1)Study completedNCT03713242What this trial is testingEvaluate the Pharmacokinetics of ACT-541468 in Subjects With Mild, Moderate, and Severe Hepatic ImpairmentWho this might be right forHepatic Impairment Idorsia Pharmaceuticals Ltd. 32
Early research (Phase 1)Looking for participantsNCT07023354What this trial is testingTest How BI 1291583 is Taken up in the Blood of People With and Without Liver ProblemsWho this might be right forHealthyHepatic Impairment Boehringer Ingelheim 32
Early research (Phase 1)Not Yet RecruitingNCT07457190What this trial is testingPharmacokinetic Study of Buagafuran Capsules in Participants With Hepatic Impairment and Normal Hepatic FunctionWho this might be right forGeneralized Anxiety Disorder Beijing Union Pharmaceutical Factory Ltd 24
Early research (Phase 1)Study completedNCT03277274What this trial is testingEvaluate the Effect of Hepatic Impairment on the Single Dose Pharmacokinetics (PK) of Intravenous TAK-954Who this might be right forHepatic ImpairmentHealthy Volunteers Takeda 25
Early research (Phase 1)Study completedNCT01670734What this trial is testingPharmacokinetic and Tolerability of Alirocumab SAR236553 (REGN727) in Patients With Hepatic Impairment and in Healthy SubjectsWho this might be right forHypercholesterolemia Sanofi 25
Early research (Phase 1)Study completedNCT05560464What this trial is testingEvaluation of the Pharmacokinetics and Safety of VX-548 in Participants With Mild or Moderate Hepatic ImpairmentWho this might be right forPain Vertex Pharmaceuticals Incorporated 36
Early research (Phase 1)Study completedNCT06425198What this trial is testingStudy to Assess Drug Levels and Safety of BMS-986278 in Healthy Participants and Participants With Different Degrees of Hepatic ImpairmentWho this might be right forHepatic ImpairmentHealthy Participants Bristol-Myers Squibb 37
Early research (Phase 1)Study completedNCT01012284What this trial is testingTMC207 in Patients With Moderately Impaired Hepatic FunctionWho this might be right forModerate Hepatic Impairment Tibotec BVBA 16
Early research (Phase 1)Study completedNCT02318836What this trial is testingSingle-Dose Pharmacokinetics and Safety of Oral Lofexidine in Hepatically-Impaired SubjectsWho this might be right forLiver Failure USWM, LLC (dba US WorldMeds) 24
Early research (Phase 1)Study completedNCT00736905What this trial is testingTMC278-TiDP6-C130: Pharmacokinetics, Safety and Tolerability of TMC278 in Subjects With Mildly or Moderately Impaired Hepatic Function.Who this might be right forHIVAIDSHepatic Impairment Tibotec Pharmaceuticals, Ireland 32
Early research (Phase 1)Study completedNCT06692322What this trial is testingTest How Zongertinib is Taken up in the Blood of People With and Without Liver ProblemsWho this might be right forLiver DiseasesHealthy Boehringer Ingelheim 29
Early research (Phase 1)Study completedNCT02161770What this trial is testingStudy to Assess the Blood Levels and Safety of AZD9291 in Patients With Advanced Solid Tumours and Normal Liver Function or Mild or Moderate Liver ImpairmentWho this might be right forSolid Tumours AstraZeneca 30